Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
|
Expensive Performer
6215.0000
103.00
(
1.69
%)
NSE
Sep 19, 2025
13:04 PM
25.43% Gain from 52W Low
Volume:
466.3K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
23 May 2022
6215.00
1.69%
Ends FY22 on a strong note
Buy:
Divi's Laboratories Ltd.
by
Motilal Oswal
Target: 4480
Target
Motilal Oswal
Number of FII/FPI investors increased from 922 to 990 in Jun 2025 qtr.
More from Divi's Laboratories Ltd.
Recommended
Market trades lower, Kaynes Tech CEO Rajesh Sharma resigns
Trendlyne Marketwatch |
19 Sep 2025, 01:02PM
Bull run fizzles out: Multibagger count in Indian equities falls
The Baseline |
18 Sep 2025, 03:38PM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022